Abnormal immunity of non-survivors with COVID-19: predictors for mortality

Y Zhao, HX Nie, K Hu, XJ Wu, YT Zhang… - Infectious diseases of …, 2020 - Springer
Background The number of coronavirus disease 2019 (COVID-19) cases has rapidly
increased all over the world. Specific information about immunity in non-survivors with …

Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China

R Chen, L Sang, M Jiang, Z Yang, N Jia, W Fu… - Journal of Allergy and …, 2020 - Elsevier
Background Crucial roles of hematologic and immunologic responses in progression of
coronavirus disease 2019 (COVID-19) remain largely unclear. Objective We sought to …

[HTML][HTML] Hematological profile and biochemical markers of COVID-19 non-survivors: A retrospective analysis

M Bairwa, R Kumar, K Beniwal, D Kalita… - … Epidemiology and Global …, 2021 - Elsevier
Background Coronavirus disease is primarily transmitted through the respiratory route and
bodily contact. The fatality in COVID-19 cases was alarming in the initial days. This study …

Clinical and laboratory features of COVID-19: Predictors of severe prognosis

A Bastug, H Bodur, S Erdogan, D Gokcinar… - International …, 2020 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19) emerged first in December
2019 in Wuhan, China and quickly spread throughout the world. Clinical and laboratory data …

Increased circulating level of interleukin-6 and CD8+ T cell exhaustion are associated with progression of COVID-19

PH Yang, YB Ding, Z Xu, R Pu, P Li, J Yan… - Infectious diseases of …, 2020 - mednexus.org
Background: Coronavirus disease 2019 (COVID-19) is pandemic. It is critical to identify
COVID-19 patients who are most likely to develop a severe disease. This study was …

The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report

C Hu, J Li, X Xing, J Gao, S Zhao, L Xing - PLoS One, 2021 - journals.plos.org
Background In December 2019, a new disease named coronavirus disease 2019 (COVID-
19) was occurred. Patients who are critically ill with COVID-19 are more likely to die …

The clinical course and its correlated immune status in COVID-19 pneumonia

R He, Z Lu, L Zhang, T Fan, R Xiong, X Shen… - Journal of Clinical …, 2020 - Elsevier
Objectives To explore the clinical course and its dynamic features of immune status in
COVID-19 patients and find predictors correlated with severity and prognosis of COVID-19 …

Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis

L Yang, J Jin, W Luo, Y Gan, B Chen, W Li - PloS one, 2020 - journals.plos.org
Background Early and accurate prognosis prediction of the patients was urgently warranted
due to the widespread popularity of COVID-19. We performed a meta-analysis aimed at …

Early phases of COVID-19 are characterized by a reduction in lymphocyte populations and the presence of atypical monocytes

A Lombardi, E Trombetta, A Cattaneo… - Frontiers in …, 2020 - frontiersin.org
Background Severe acute respiratory syndrome coronavirus 2 is a recently discovered
pathogen responsible of coronavirus disease 2019 (COVID-19). The immunological …

Dysregulation of the immune response affects the outcome of critical COVID‐19 patients

L Wei, W Wang, D Chen, B Xu - Journal of Medical Virology, 2020 - Wiley Online Library
Critical cases of coronavirus disease 2019 (COVID‐19) are associated with a high risk of
mortality. It remains unclear why patients with the same critical condition have different …